Global Companion Diagnostics Market Report By Technology Type (Immunohistochemistry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), In Situ Hybridization, Others), By Indication (Oncology, Neurology, and Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212839
July 2020
Report Formats:

The global demand for Companion Diagnostics Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Companion diagnostic provides information that is essential for effective and safe use of the corresponding drug or biological product. This helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potentially serious side effects or risks. The ultimate goal is to stimulate faster access to promising new treatments for patients living with serious and life-threatening diseases.
 
Market Dynamics
 
Companion diagnostics are a crucial part of personalized medicine and will likely continue to rapidly increase in the number of disease areas. The next generation of drugs has to be safer and more efficacious. Companion diagnostics are one of the tools that can generate this information and make it available to drug developers. Escalating activities of drug discovery and vaccine development will be driving the market growth. Oncology is a segment of major focus and will remain at the forefront for the foreseeable future. Companion diagnostic play a major role in oncology research and has revolutionized the treatment of cancer by allowing doctors to adjust drug therapy to achieve better clinical results.  However, the high cost and uncertain reimbursement scenario in a different region are hampering the growth of the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of companion diagnostics.
 
Market Segmentation
 
The entire companion diagnostics market has been sub-categorized into technology type, and indication. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Technology Type

  • Immunohistochemistry
  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • In Situ Hybridization
  • Others
 
By Indication
  • Oncology
  • Neurology
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for companion diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Companion Diagnostics Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the companion diagnostics market include Abbott Laboratories Molecular, Inc., Agilent, ARUP Laboratories, Inc., BioMerieux SA, Danaher Corporation. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Companion Diagnostics Market
       2.2. Global Companion Diagnostics Market Snapshot
 
3 . COMPANION DIAGNOSTICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Companion Diagnostics Market
       3.3. Market Restraints of Companion Diagnostics Market
       3.4. Opportunities of Companion Diagnostics Market
       3.5. Trends of Companion Diagnostics Market
       3.6. Porter’s Five Force Analysis of Companion Diagnostics Market
       3.7. Companion Diagnostics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Technology Type
           3.7.2 Market Attractive Analysis by Indication
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Companion Diagnostics Value Chain Analysis
       4.2. Companion Diagnostics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Companion Diagnostics Raw Material Manufactures List
           4.2.3. Price Trend of Companion Diagnostics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Companion Diagnostics Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Companion Diagnostics Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Companion Diagnostics Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Companion Diagnostics Market
 
6 . GLOBAL COMPANION DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY TYPE
       6.1 Overview by Technology Type
       6.2 Historical Data 2015-2018
       6.3 Global Companion Diagnostics Market Analysis by Technology Type
       6.4 Market Analysis of Immunohistochemistry by Regions
       6.6 Market Analysis of Polymerase Chain Reaction by Regions
       6.5 Market Analysis of Next Generation Sequencing by Regions
       6.7 Market Analysis of In Situ Hybridization by Regions
       6.8 Market Analysis of Others by Regions
 
7 . GLOBAL COMPANION DIAGNOSTICS MARKET ANALYSIS BY INDICATION
       7.1 Overview by Indication
       7.2 Historical Data 2015-2018
       7.3 Global Companion Diagnostics Market Analysis by Indication
       7.4 Market Analysis of Oncology by Regions
       7.5 Market Analysis of Neurology by Regions
       7.6 Market Analysis of Others by Regions
 
8 . GLOBAL COMPANION DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview and Historic Data
           8.3.2. North America Companion Diagnostics Market Estimate By Market Segment
           8.3.3. North America Companion Diagnostics Market Estimate By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview and Historic Data
           8.4.2. Europe Companion Diagnostics Market Estimate by Market Segment
           8.4.3. Europe Companion Diagnostics Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview and Historic Data
           8.5.2. Asia Pacific Companion Diagnostics Market Estimate by Market Segment
           8.5.3. Asia Pacific Companion Diagnostics Market Estimate by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview and Historic Data
           8.6.2. Latin America Companion Diagnostics Market Estimate by Market Segment
           8.6.3. Latin America Companion Diagnostics Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview and Historic Data
           8.7.2. Middle East & Africa Companion Diagnostics Market Estimate by Market Segment
           8.7.3. Middle East & Africa Companion Diagnostics Market Estimate by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE COMPANION DIAGNOSTICS COMPANIES
       9.1. Companion Diagnostics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF COMPANION DIAGNOSTICS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Abbott Laboratories Molecular, Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Agilent
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. ARUP Laboratories, Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. BioMerieux SA
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Danaher Corporation
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Companion Diagnostics Market Snapshot
  • Drivers of The Global Companion Diagnostics Market Impact Analysis
  • Restraints of The Global Companion Diagnostics Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Companion Diagnostics Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Companion Diagnostics Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Companion Diagnostics Market
  • Global Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Historic Data 2015-2018
  • Global Companion Diagnostics Market Analysis in Immunohistochemistry by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in Polymerase Chain Reaction by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in Next Generation Sequencing by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in In Situ Hybridization by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in Others by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis by Indication ( USD MN)
  • Historic Data 2015-2018
  • Global Companion Diagnostics Market Analysis in Oncology by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in Neurology by Geography ( USD MN)
  • Global Companion Diagnostics Market Analysis in Others by Geography ( USD MN)
  • Global Companion Diagnostics Market by Geography ( USD MN)
  • Historic Data 2015-2018
  • North America Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • North America Companion Diagnostics Market Estimate by Indication ( USD MN)
  • North America Companion Diagnostics Market Estimate by Country ( USD MN)
  • United State Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • United State Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Canada Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Canada Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Mexico Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Mexico Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Europe Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Europe Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Europe Companion Diagnostics Market Estimate by Country ( USD MN)
  • United Kingdom Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • United Kingdom Companion Diagnostics Market Estimate by Indication ( USD MN)
  • France Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • France Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Germany Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Germany Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Italy Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Italy Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Russia Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Russia Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Spain Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Spain Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Rest of Europe Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Rest of Europe Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Asia Pacific Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Asia Pacific Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Asia Pacific Companion Diagnostics Market Estimate by Country ( USD MN)
  • China Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • China Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Japan Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Japan Companion Diagnostics Market Estimate by Indication ( USD MN)
  • India Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • India Companion Diagnostics Market Estimate by Indication ( USD MN)
  • South Korea Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • South Korea Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Australia Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Australia Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Rest of Asia Pacific Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Rest of Asia Pacific Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Latin America Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Latin America Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Latin America Companion Diagnostics Market Estimate by Country ( USD MN)
  • Brazil Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Brazil Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Argentina Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Argentina Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Peru Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Peru Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Chile Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Chile Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Rest of Latin America Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Rest of Latin America Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Middle East & Africa Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Middle East & Africa Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Middle East & Africa Companion Diagnostics Market Estimate by Country ( USD MN)
  • Saudi Arabia Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Saudi Arabia Companion Diagnostics Market Estimate by Indication ( USD MN)
  • UAE Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • UAE Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Israel Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Israel Companion Diagnostics Market Estimate by Indication ( USD MN)
  • South Africa Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • South Africa Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Rest of Middle East and Africa Companion Diagnostics Market Analysis by Technology Type ( USD MN)
  • Rest of Middle East and Africa Companion Diagnostics Market Estimate by Indication ( USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Companion Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Companion Diagnostics Market Size, by Region (2019)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Companion Diagnostics Market Analysis by Technology Type
  • Global Companion Diagnostics Market Analysis in Immunohistochemistry by Region
  • Global Companion Diagnostics Market Analysis in Polymerase Chain Reaction by Region
  • Global Companion Diagnostics Market Analysis in Next Generation Sequencing by Region
  • Global Companion Diagnostics Market Analysis in In Situ Hybridization by Region
  • Global Companion Diagnostics Market Analysis in Others by Region
  • Global Companion Diagnostics Market Analysis by Indication
  • Global Companion Diagnostics Market Analysis in Oncology by Region
  • Global Companion Diagnostics Market Analysis in Neurology by Region
  • Global Companion Diagnostics Market Analysis in Others by Region
  • Global Companion Diagnostics Market by Revenue
  • North America Companion Diagnostics Market by Revenue
  • Europe Companion Diagnostics Market by Revenue
  • Asia Pacific Companion Diagnostics Market by Revenue
  • Latin America Companion Diagnostics Market by Revenue
  • Middle East & Africa Companion Diagnostics Market by Revenue
  • Recent Development in Companion Diagnostics Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials